Longitude Prize on ALS supports multidisciplinary teams using AI to discover, prioritise and validate therapeutic targets, seeking the strongest evidence of potential to advance ALS treatment.
ALS Finding a Cure funds research using AI and NLP to advance ALS diagnostics, biomarker discovery, disease modeling, and therapeutic innovation.
Industry-Led Consortia supports industry and academic researchers developing translational evidence for novel therapeutics to expand treatment options for familial and sporadic ALS.
The Hoffman ALS Clinical Trial Awards Program supports researchers conducting biomarker-driven early trials of ALS therapies and imaging tracers to advance treatment development and care.
Seed Grants from the ALS Association support investigators conducting critical experiments to generate preliminary data for larger ALS research efforts aimed at treatments, cures, better care, or prevention.
The Lawrence and Isabel Barnett Drug Development Program supports academic and industry investigators conducting preclinical studies of new or repurposed ALS therapies to advance them toward clinical testing.